US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veraxa Biotech Holding AG

1.64

-0.0900-5.20%

Post-market: 1.61-0.0300-1.83%19:30 EDT

Volume:425.41K

Turnover:711.41K

Market Cap:231.91M

PE:7.66

High:1.85

Open:1.85

Low:1.57

Close:1.73

52wk High:27.36

52wk Low:1.57

Shares:141.41M

Float Shares:41.01M

Volume Ratio:3.51

T/O Rate:1.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2142

EPS(LYR):-2.2094

ROE:-65.29%

ROA:-20.46%

PB:6.01

PE(LYR):-0.74

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase

VERAXA Biotech (NASDAQ: VRXA) Builds Antibody-Based Cancer Pipeline Around Dual-Targeting Precision

Veraxa Biotech Ag: Successful in Vitro Proof-of-Concept Study Shows Potential to Create Novel Aocs by Combining Both Parties’ Tech & Expertise

THOMSON REUTERS

Veraxa Biotech Ag: Co & Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate Alliance

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigerhkgo.com/stock/VRXA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VRXA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","market":"US","secType":"STK","nameCN":"Veraxa Biotech Holding AG","latestPrice":1.64,"timestamp":1787774400000,"preClose":1.73,"halted":0,"volume":425410,"hourTrading":{"tag":"盘后","latestPrice":1.61,"preClose":1.64,"latestTime":"19:30 EDT","volume":2230,"amount":3610.1409,"timestamp":1787787048460,"change":-0.03,"changeRate":-0.018293,"amplitude":0.018293},"delay":0,"changeRate":-0.05202312138728328,"floatShares":41012504,"shares":141407813,"eps":0.2142,"marketStatus":"Not Yet Opened","change":-0.09,"latestTime":"08-26 16:00:00 EDT","open":1.85,"high":1.85,"low":1.57,"amount":711406.293899,"amplitude":0.16185,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.2142,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787817600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":1.73,"preHourTrading":{"tag":"盘前","latestPrice":1.85,"preClose":1.73,"latestTime":"09:29 EDT","volume":1696,"amount":3100.5388384000003,"timestamp":1787750975003,"change":0.12,"changeRate":0.069364,"amplitude":0.046243},"postHourTrading":{"tag":"盘后","latestPrice":1.61,"preClose":1.64,"latestTime":"19:30 EDT","volume":2230,"amount":3610.1409,"timestamp":1787787048460,"change":-0.03,"changeRate":-0.018293,"amplitude":0.018293},"volumeRatio":3.506974},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","floatShares":41012504,"roa":"-20.46%","roe":"-65.29%","lyrEps":-2.209413,"volumeRatio":3.506974,"shares":141407813,"dividePrice":0,"high":1.85,"amplitude":0.16185,"preClose":1.73,"low":1.57,"week52Low":1.57,"pbRate":"6.01","week52High":27.36,"institutionHeld":0,"latestPrice":1.64,"eps":0.2142,"divideRate":0,"volume":425410,"delay":0,"ttmEps":0.2142,"open":1.85,"prevYearClose":18.65,"prevWeekClose":1.95,"prevMonthClose":1.76,"prevQuarterClose":1.88,"fiveDayClose":1.86,"twentyDayClose":1.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRXA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRXA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRXA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRXA","date":"2026-08-25","current":7.656396,"percent":1,"low":-1.401348,"twenty":-1.372549,"median":-1.34261,"eighty":-1.311559,"high":-1.281094,"avg":-1.341915,"sd":0.043195,"marketCap":44886820},"quantilePoints":[{"date":"2026-08-21","current":-1.35335,"twenty":-1.349054,"median":-1.34261,"eighty":-1.336165,"marketCap":47660725},{"date":"2026-08-25","current":-1.281094,"twenty":-1.372549,"median":-1.34261,"eighty":-1.311559,"marketCap":44886820}],"updateTime":1787809933629},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRXA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662530737","title":"VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2662530737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662530737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 23:00","pubTimestamp":1787670008,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, August 25th, 2026, FinanceWire Following completion of the initial phase of its collaboration with OmniAb, VERAXA wil...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-vxa-222-cancer-program-beyond-discovery-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-vxa-222-cancer-program-beyond-discovery-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IYW","TECS","BK4139","VRXA","BK4581","JEPQ","NDX","TQQQ",".IXIC","QQQ","GPIQ","QQQJ","SQQQ","QQQY","QYLG","NQmain","ONEQ","TQQY","QQQE","QDTE","BK4585","NVIW.SI","QLD","QQQA","XBI","PSQ","MNQmain","FTEC","QQQM","QID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662083312","title":"VERAXA Biotech (NASDAQ: VRXA) Builds Antibody-Based Cancer Pipeline Around Dual-Targeting Precision","url":"https://stock-news.laohu8.com/highlight/detail?id=2662083312","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662083312?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:00","pubTimestamp":1787590833,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, August 24th, 2026, FinanceWire VERAXA Biotech is changing how antibody-based therapies recognize and attack cancer ce...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-builds-antibody-based-cancer-pipeline-around-dual-targeting-precision?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-builds-antibody-based-cancer-pipeline-around-dual-targeting-precision?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQ","BK4139","NDX","QQQJ","IYW","GPIQ","MNQmain",".IXIC","QQQE","PSQ","QLD","QID","NQmain","FTEC","VRXA","BK4581","QDTE","QQQY","XBI","BK4585","TQQY","JEPQ","NVIW.SI","ONEQ","QQQM","QYLG","TECS","SQQQ","TQQQ","BK4588","QQQA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661427591","title":"Veraxa Biotech Ag: Successful in Vitro Proof-of-Concept Study Shows Potential to Create Novel Aocs by Combining Both Parties’ Tech & Expertise","url":"https://stock-news.laohu8.com/highlight/detail?id=2661427591","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661427591?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:41","pubTimestamp":1787571679,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L08R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRXA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275959","title":"Veraxa Biotech Ag: Co & Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate Alliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275959","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275959?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:41","pubTimestamp":1787571679,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L08R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRXA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":17,"pageCount":1,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VRXA\",params:#limit:6,delay:false,,,undefined,":[]}}